

19 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/phase-2-clinical-trial-results-show-potential-to-shorten-tb-treatment-time-302619952.html

19 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/promising-new-data-on-pediatric-use-of-pretomanid-in-children-with-drug-resistant-tuberculosis-presented-at-2025-union-conference-302620125.html

24 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/price-of-key-dr-tb-medicine-drops-25-as-tb-alliances-multi-manufacturer-strategy-expands-access-302437668.html

12 Aug 2020
// EMA
https://www.ema.europa.eu/en/documents/overview/pretomanid-fgk-epar-medicine-overview_en.pdf

22 Jul 2020
// John Carroll ENDPTS
https://endpts.com/ayahuasca-inspires-another-biotech-startup-at-atai-mylan-tb-drug-gets-green-light-in-india/
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-march-2020